Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

Clinical trial NCT01673282 · COMPLETED

Trial details

NCT number: NCT01673282
Sponsor: UCB Pharma GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Focal Epilepsy With and Without Secondary Generalization

Start date: 2012-07-01
Primary completion: 2015-07-01
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.